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1. Introduction 
There is increasing interest in lectins of animal 
tissues [ 11. A lectin isolated from calf hearts reacts 
with glycoproteins having Galpl-*4GlcNAc sequences 
at their non-reducing termini [2], for example glyco- 
peptides derived from bovine thymocytes containing 
Galfll+4GlcNAc/31+3 (or 6) structures [3]. It is 
known that the blood group I antigen is carried on 
the branched oligosaccharide 
Galp 1+4GlcNAc/31 4
6Gal 
[4,5] and the i antigen is expressed predominantly on 
straight chain oligosaccharides containing the sequence 
G@l+4GlcNAcf31+3Gal [6]. Both are found as 
cryptic antigens on the core oligosaccharides of blood 
group ABH-active secreted glycoproteins [4,7], 
erythrocyte glycolipids and gangliosides [5,6,8] and 
as detectable surface antigens on human erythrocytes 
[9], leucocytes [lo] and a variety of animal cell 
types (R. C., T. F., unpublished observations). They 
are of special interest because of the developmental 
changes in their expression on human erythrocytes 
[9], cell cycle related changes on lymphocytes [ 1 l] 
and their increased expression in certain human 
adenocarcinoma tissues [ 121. Therefore we have 
investigated the possible role of the blood group I and 
i antigens as natural receptors for the calf heart lectin. 
Parallel studies with the /I-galactosyl-specific plant 
lectin, Ricinus communis agglutinin 120 [ 131 have 
shown that: 
(a) The calf heart lectin shows more specificity for 
the terminal disaccharide units of blood group 
antigen precursor chains than does the plant 
lectin; 
(b) Ii-active (blood group ABH-inactive) mucins are 
more potent inhibitors of both lectins than ABH 
active (Ii inactive) mucins; 
(c) Calf heart tissue contains I and i antigens which 
are potent inhibitors of both lectins. 
2. Experimental 
The soluble lectin was isolated from an homogenate 
of calf hearts, as in [2] using an asialofetuln adsorbent 
column. R. communis agglutinin 120 was purchased 
from Miles Labs Ltd, Slough. The lectins were labelled 
with carrier-free “‘1 (The Radiochemical Centre, 
Amersham) by the chloramine T method [ 141. The 
iodination mixture contained lactose at 20 mM final 
cont. Specific activities were 1.8 X 10’ cpm/ng calf 
lectin and 3 X lo3 cpm/ng R. communis agglutinin, 
as measured by a Nuclear Enterprises 1600 gamma 
counter. 
Inhibition of binding assays with the lectins were 
a modification of the method in [2]: 10 ~1 serial lo- 
fold dilutions of inhibitors were incubated at 4°C 
with either 10 @(50 ng) ‘251-labelled calf heart lectin 
or 10 ,ul (12 ng) 1251-labelled R. communis agglutinin 
in 20 ~1 either a solution of 0.85% NaCl, 0.01 M 
NH&C03, 1 mM dithiothreitol, 1 mg/ml bovine 
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serum albumin (BSA); or 50 mM phosphate-buffered 
saline, pH 7.4 (PBS), I mg/ml BSA, respectively. 
After 60 min, 10 ~1 packed, freshly prepared, trypsi- 
nized rabbit erythrocytes (-8 X lo6 cells) were added 
and the incubation continued for a further 60 min. 
The cells were then washed twice with 0.5 ml 0.85% 
NaCl and their radioactivity measured. All points 
were performed in duplicate, The counts in the nega- 
tive control tubes (labelled lectin without erythro- 
cytes and inhibitor) were subtracted from all counts 
in the assays and inhibitory activity was expressed 
as either nmol non-reducing galactose termini (oligo- 
saccharides) or &ml (mucins) giving 50% inhibition 
of binding of the lectins relative to the positive con- 
trols. 
As inhibitors, the following oligosaccharides were 
used: lactose (Sigma Chemical Co.): Gal/31+4GlcNAc 
(gift of Dr E. A. Kabat); Gal@l+3GlcNAc and 
Gal~I+6GlcNAc (gifts of Dr Adeline Gauhe); the 
straight chain trisaccharides, the branched tri-, tetra- 
and penta-saccharides (table 1) were synthesized in 
the laboratory of Dr S. David [ 151; the branched 
octasaccharide isolated from the urine of a patient 
with GM 1 gangliosidosis [ 161 was a gift from Dr A. 
Lundblad. 
The following three types of complex glycopro- 
teins (mucins) were tested for their reactions with 
the two lectins: 
(a) Substanceslacking blood group A, B, H and Lewis 
activities but showing I and i activities as recog- 
nized by all 11 anti-1 and anti-i sera tested [4,7,17]; 
these were, ovarian cyst blood group precursor- 
like substance Fl , a glycoprotein-rich extract of 
human meconium, Met and a preparation of 
sheep gastric mucin; 
(b) Human ovarian cyst blood group substances 
without demonstrable I and i activities (4,7,17]; 
MSS (blood group A-active), Beach (blood group 
B-active) and JS (blood group HLeb-active); 
(c) Substances showing activities only with certain 
of the anti-1 and anti-i antisera tested [4,7,17]; 
these were, ovarian cyst substances 413 (blood 
group B-active), N-l phenol insol (blood group 
Lea-active), 484 and 502 (both lacking in A, B, 
H and Lewis activities) and the products of one 
stage of Smith (periodate) degradation (1st IO,) 
[4] of substances MSS, Beach and JS. 
I and i antigens were isolated from a clear super- 
176 
natant of heart homogenate (depleted of lectin by 
passage over an asialofetuin adsorbent) by affinity 
chromatography on an anti-1 adsorbent [ 181. 
3. Results and discussion 
Both lectins were better inhibited by Gal~l~4GlcNAc 
than by lactose (table 1). The calf heart lectin was 
equally well inhibited by the disaccharides Galfll+ 
3GlcNAc and Gal~I-+4GlcNAc which occur as the 
non-reducing termini (type 1 and type 2 chains, res- 
pectively) of glycoprotein precursors of the blood 
group antigens [19]; it was not i~ibited by the isomer 
Ga.l~1+6GlcNAc (which has not been observed on 
blood group antigen precursors) at the highest con- 
centration tested. The R. communis lectin reacted 
best with Gal@-+4GlcNAc and less well with the 
I+3 and I+,6 linked isomers and did not distinguish 
between these two latter disacch~ides. With the calf 
lectin the inhibitory activities of straight chain tri- 
saccharides and branched oligosaccharides containing 
terminal GalP1+4GlcNAc and/or Gal/?l+3GlcNAc 
units were comparable (per mol/non-reducing galac- 
tose) with the disaccha~des Gal/II*4 (or 3) GlcNAc, 
indicating that the linkage of the penultimate GlcNAc 
to an internal galactose (or mannose) does not affect 
binding to this lectin. Thus, the calf lectin, while 
distinguishing l-+4- and l-+3-linked terminal oligo- 
saccharide units from I-+6-linked units, does not 
distingui~ between Gal~l~4GlcNAc~ l-23 (or 6) - 
sequences associated with I and i specificities 
[4,6,15,21] and GalfJl+3GlcNAc~l-+3 (or 6) -and 
Gal~l-+4GlcNAc/31-+2 - sequences which have no 
demonstrable I or i activities [4,15] and weak I activ- 
ities, respectively (E. Wood, A. Lundblad, T. F., 
unpublished observations). Neither lectin was i~ibited 
by the branched trisaccharide with two terminal 
GlcNAc residues linked /31-+6 and /II-+3 to Gal. 
Among the mucins (table 2) the strongly Ii-active 
substances (a) showed the highest inhibitory activities 
with both lectins, and the blood group A, B, H, Leb- 
active (Ii-inactive) substances (b) which must have a 
large proportion of substituted precursor chains, were 
much less inhibitory unless Ii-active oligosaccharide 
determinants were exposed by periodate degradation. 
The substances with varying Ii activities (c) showed a 
range of inhibitory activities with the lectins. 
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Table 1 
Comparison of the potency of oligosaccharides in inhibiting the binding of radioiodinated calf 
heart lectin and R. communis 120 agglutinin. to trypsinized rabbit erythrocytes 
Oligosaccharides nmol non-reducing alactose termini 
giving 50% inhibition of binding 
Calf heart R. communis 
lectin agglutinin 
Galpl-4Glc (lactose) 
Ga@ 1 -4GlcNAca 
Galpl-3GlcNAc 
Galpl-6GlcNAc 
Galfll-4GlcNAcpl-3Gala 
Galpl-4GlcNAcpl-+6Gala 
Galpl-3GlcNAcpl-+3Gal 
Galpl-3GlcNAcpl-6Gal 
GlcNA@l 
18 28 
4.9 9.5 
4.1 27 
> 54 24 
5.7 19 
5.7 12, 
5.7 > 38 
5.7 57 
‘6 
.3 
Gal 8.4 194 
Galpl-+3GlcNAcpl’ 
Gal@l-+4GlcNAc~l I 
‘6 
.3 
Gal 4.6 16 
Galpl-3GlcNAcpl 
Gal/31-+4GlcNAcpl-+2Manal \ 
-3 
6 
Manpl-4GlcNAca 4.2 12 
G&31-4GlcNAcpl-2Manorlf 
GlcNAc$l 
‘6 
3 
Gal > 364 > 364 
GlcN A@1 ’ 
a Exhibit inhibitory activity toward certain anti-1 or anti-i antibodies (4,15,21 I, E. Wood, 
A. Lundblad, T. F., unpublished observations) 
Since the I and i antigens contain recognition sites 
for the calf lectin, we examined the calf heart homog- 
enate for the presence of I and i antigens. The eluate 
from the anti-1 adsorbent column, 0.85 mg dry wt, 
containing 2% hexose (as determined by phenol 
sulphuric acid assay) [20] was tested for inhibitory 
activity with two anti-1 sera (Ma and Step) and one 
anti-i serum (Tho), by radioimmunoassy [8 ,I 51. It 
had potent inhibitory activity (relative to its hexose 
content) with all three antisera, giving 50% inhibition 
of binding of the anti-1 and -i sera to a radioiodinated 
Ii-active glycoprotein at concentrations of 0.3, 1 and 
6 1.19 hexose/ml, respectively. The eluate also had 
inhibitory activity toward the calf lectin and the 
R. communis lectin at hexose concentrations of 
60 E.cg/ml and 1 I.cg/ml, respectively (table 2). 
These studies show that among blood group sub- 
stances, those with I and i activities carry receptors 
for the calf and the R. communis lectins and raise the 
possibility that I and i antigens may be among natural 
receptors for the former. Immunocytochemical studies 
should identify the cellular location of Ii antigens in 
heart tissues and their relationship to the distribution 
of the lectin. 
Calf heart lectin may be only one among several 
which has been selected for and enriched from heart 
177 
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Table 2 
Compriaon of the potency of blood group substances with and without Ii activities in inhibiting the binding 
of radioiod~ated calf heart lectin and R. ~rnrnu~~ 120 agglutlnin to trypsinized rabbit erythrocytes 
Inhibitors No. anti-l 
or -i sera 
inhibited 
Concentration @g/ml) giving 
50% inhibition of binding 
Calf heart R. communis 
lectin agglutinin 
(4 
@I 
w 
Reactive with ail anti-1 and -1 sera 
Fl 
Met 
Sheep gastric mucin 
Not reactive with anti-1 and -i sera 
MSS 
Beach 
JS 
Reactive with certain anti-1 and -i sera 
413 
N-l phenol insoluble 
484 
SO2 
MSS 1st IO, 
Beach 1st IO, 
JS 1st IO, 
11a 100 0.45 
11 45 1 
11 90 0.6 
0 
0 
0 
7 320 20 
2 650 6 
5 250 30 
4 300 30 
3 100 7 
4 90 1 
2.. 500 > 1200 
> 1000 
1500 
450 
20 
170 
40 
Ii active substance from calf heart 3O 60 1 
a The figures indicate the number of anti-1 or anti-i sera inhibited by each mu&n 
b The Ikctive substance hrted from the supernatant of the calf heart homogenate was tested with only 
two anti-l and one anti-i sera. The inhibitory activity of this substance with the two lectins wasexpressed as 
Mg hexose/ml giving 50% inhibition. The hexose content of this substance was 2% compared with 
20-30% for the mu&s 
The blood group I and i activities of the mucins have been evaluated with 11 antisera (6 anti-1 and 5 anti-i) 
by ra~oimmunoas~ys [ 171 
homogenate by adsorption to asialofetuin and elution 
with lactose. Future studies with other carbohydrate 
adsorbents and elution with more complex oligosac- 
charide chains may reveal more di~~minato~ lectins. 
Such an approach would open the way for the sys- 
tematic investigation of the biological functions of 
defined cell surface carbohydrate structures, uch as 
the blood group antigens and their specific membrane- 
associated lectins. 
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